Mortsel, Belgium – March 30, 2022 – 5:40 p.m. CET
Notification pursuant to Article 15 of the Act of 2 May 2007 concerning the disclosure of significant participations in issuers whose shares are admitted to trading on a regulated market
As a result of the decision of the Board of Directors on March 9, 2021, the company, by notarial deed dated March 30, 2022, cancelled a total of 2,299,218 treasury shares. This decision was taken in accordance with the authorization granted to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020.
The new data concerning the company's shares and capital following this
transaction is as follows:
Old number of outstanding shares: 160,506,706
Number of cancelled shares: 2,299,218
New number of outstanding shares (denominator): 158,207,488
Share capital: 186,794,611.00 Euro
Total number of voting rights: 158,207,488
Total number of voting securities: 158,207,488
Total number of shares without voting rights: 0
About Agfa
The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2021, the Group realized a turnover of 1,760 million Euro.
Contact:
Viviane Dictus
Director Corporate Communication
T +32 (0) 3 444 71 24
E viviane.dictus@agfa.com
Johan Jacobs
Corporate Press Relations Manager
T +32 (0)3/444 80 15
E johan.jacobs@agfa.com
Attachment
